MedPath

A clinical study to compare between intravenous dexmedetomidine and intravenous lignocaine in decreasing the hemodynamic responses to laryngoscopy and tracheal intubation.

Phase 4
Conditions
Health Condition 1: R688- Other general symptoms and signsHealth Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2022/08/044986
Lead Sponsor
Dr Anamika Majumdar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age between 18 to 60 years

2. American Society of Anaesthesiologists physical status 1 and 2

3. Who has given written and informed consent

Exclusion Criteria

1. Who has not given written informed consent

2. Patients with heart rate less than 60 per minute

3. Patients with anticipated difficult intubation

4. Patients with systolic blood pressure less than 100 mmHg

5. Patients with history of cardiac , renal, cerebral, peripheral vascular disease, obesity , pregnant woman and nursing mothers

6. History suggestive of sensitivity to drugs used in the study

7. Intubation attempts lasting more than 30 seconds

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath